High-amylose Resistant Starch Research Articles

The effect of high-amylose resistant starch on the glycogen structure of diabetic mice

Glycogen is a complex branched glucose polymer found in many tissues and acts as a blood-glucose buffer. In the liver, smaller β glycogen particles can bind into larger composite α particles. In mouse models of diabetes, these liver glycogen particles are molecularly fragile, breaking up into smaller particles in the presence of solvents such as dimethyl sulfoxide (DMSO). If this occurs in vivo, such a rapid enzymatic degradation of these smaller particles into glucose could exacerbate the poor blood-glucose control that is characteristic of the disease. High-amylose resistant starch (RS) can escape digestion in the small intestine and ferment in the large intestine, which elicits positive effects on glycemic response and type 2 diabetes. Here we postulate that RS would help attenuate diabetes-related liver glycogen fragility. Normal maize starch and two types of high-amylose starch were fed to diabetic and non-diabetic mice. Molecular size distributions and chain-length distributions of liver glycogen from both groups were characterized to test glycogen fragility before and after DMSO treatment. Consistent with the hypothesis that high blood glucose is associated with glycogen fragility, a high-amylose RS diet prevented the fragility of liver-glycogen α particles. The diets had no significant effect on the glycogen chain-length distributions.

Screening dietary fibres for fermentation characteristics and metabolic profiles using a rapid in vitro approach: implications for irritable bowel syndrome.

The therapeutic value of specific fibres is partly dependent on their fermentation characteristics. Some fibres are rapidly degraded with the generation of gases that induce symptoms in patients with irritable bowel syndrome (IBS), while more slowly or non-fermentable fibres may be more suitable. More work is needed to profile a comprehensive range of fibres to determine suitability for IBS. Using a rapid in vitro fermentation model, gas production and metabolite profiles of a range of established and novel fibres were compared. Fibre substrates (n 15) were added to faecal slurries from three healthy donors for 4 h with gas production measured using real-time headspace sampling. Concentrations of SCFA and ammonia were analysed using GC and enzymatic assay, respectively. Gas production followed three patterns: rapid (≥60 ml/g over 4 h) for fructans, carrot fibre and maize-derived xylo-oligosaccharide (XOS); mild (30-60 ml/g) for partially hydrolysed guar gum, almond shell-derived XOS and one type of high-amylose resistant starch 2 (RS2) and minimal (no differences with blank controls) for methylcellulose, another high-amylose RS2, acetylated or butyrylated RS2, RS4, acacia gum and sugarcane bagasse. Gas production correlated positively with total SCFA (r 0·80, P < 0·001) and negatively with ammonia concentrations (r -0·68, P < 0·001). Proportions of specific SCFA varied: fermentation of carrot fibre, XOS and acetylated RS2 favoured acetate, while fructans favoured butyrate. Gas production and metabolite profiles differed between fibre types and within fibre classes over a physiologically relevant 4-h time course. Several fibres resisted rapid fermentation and may be candidates for clinical trials in IBS patients.

High-Amylose Resistant Starch (RS) Cookies Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis (HD) Patients

High-Amylose Resistant Starch (RS) Cookies Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis (HD) Patients

Kinetic study of staling in breads with high-amylose resistant starch

High-amylose resistant starch breads were long-stored (11 days) at 20 °C for kinetic analysis of different aspects of the staling process. Bread products were formulated on a French-bread recipe basis and replacing wheat flour by type II resistant starch at different levels: 0% (control), 10% (HM10), 20% (HM20) and 30% (HM30). Experiments included measurements of water activity, moisture loss, amylopectin retrogradation by DSC, crystallinity changes by X-ray diffraction, and firmness by texture analysis. In the presence of resistant starch water loss was slower, allowing amylopectin retrogradation to be more extensive. However, HM10 and HM20 had similar firming behavior to the control, likely due to the similar and adequate quality that these breads showed initially (at day 0). In contrast, samples with high resistant starch content such as HM30 presented a poor-quality and highly filled crumb that led to the highest firmness during storage.

High-Amylose Resistant Starch as a Functional Ingredient in Breads: a Technological and Microstructural Approach

Resistant starches (RS) are important functional fibers with high potential for the development of healthy foods. The technological, nutritional, and commercial possibilities of introducing type 2 RS in white breads were studied. Four levels of maize RS (HM) as wheat flour replacement were evaluated: 0%, 10%, 20%, and 30% (control, HM10, HM20, and HM30, respectively). Thermal transitions experiments were assessed on doughs prior to breadmaking. The bread quality was studied by specific volume, color of crust and crumb, porosity, and texture of the crumb. The microstructure of the crumb was analyzed by environmental scanning electron microscopy (ESEM). Proximate composition and in vitro starch digestibility were performed to characterize the nutritional profile of breads and estimate the glycemic index (GI). Consumer acceptability of breads was also evaluated. Breads with HM showed great performance up to 20% replacement in the specific volume, the crumb porosity, and the texture. Replacement up to 30% caused major damage to those parameters. Differential scanning calorimetry runs demonstrated that HM starch did not gelatinize under the baking conditions, as confirmed by ESEM. The presence of increasing levels of native starch is thought to have the greatest influence on reducing the crust browning, increasing the crumblier texture and decreasing starch digestibility. With respect to the control, a high and progressive reduction in the estimated GI and an outstanding increase of fiber with increasing levels of HM were found. The sensory evaluation of HM20 bread showed that this level of substitution has great consumer acceptance, giving it the chance to become a healthy substitute of white bread.

Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial.

Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM-RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients. Forty-six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM-RS2 or wheat-flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation. There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF-α, IL-6, and malondialdehyde declined significantly (P < 0.05) in the HAM-RS2-treated group but remained unchanged in the placebo-treated group. No significant difference was observed in serum Interleukin-1β (IL-1β) and hs-CRP concentrations and total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly declined and severity of constipation improved in HAM-RS2-treated patients (P < 0.05). HAM-RS2 consumption was well tolerated and did not cause discernible side effects. Administration of HAM-RS2 for eight weeks significantly reduced levels of inflammatory and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM-RS2 supplementation on clinical outcomes in end stage renal disease population.

High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease.

Inflammation is a major mediator of CKD progression and is partly driven by altered gut microbiome and intestinal barrier disruption, events which are caused by: urea influx in the intestine resulting in dominance of urease-possessing bacteria; disruption of epithelial barrier by urea-derived ammonia leading to endotoxemia and bacterial translocation; and restriction of potassium-rich fruits and vegetables which are common sources of fermentable fiber. Restriction of these foods leads to depletion of bacteria that convert indigestible carbohydrates to short chain fatty acids which are important nutrients for colonocytes and regulatory T lymphocytes. We hypothesized that a high resistant starch diet attenuates CKD progression. Male Sprague Dawley rats were fed a chow containing 0.7% adenine for 2 weeks to induce CKD. Rats were then fed diets supplemented with amylopectin (low-fiber control) or high fermentable fiber (amylose maize resistant starch, HAM-RS2) for 3 weeks. CKD rats consuming low fiber diet exhibited reduced creatinine clearance, interstitial fibrosis, inflammation, tubular damage, activation of NFkB, upregulation of pro-inflammatory, pro-oxidant, and pro-fibrotic molecules; impaired Nrf2 activity, down-regulation of antioxidant enzymes, and disruption of colonic epithelial tight junction. The high resistant starch diet significantly attenuated these abnormalities. Thus high resistant starch diet retards CKD progression and attenuates oxidative stress and inflammation in rats. Future studies are needed to explore the impact of HAM-RS2 in CKD patients.

High-Amylose Resistant Starch Increases Hormones and Improves Structure and Function of the Gastrointestinal Tract: A Microarray Study

Background/Aims: Type 2 resistant starch from high-amylose maize (HAM-RS2) is associated with increased fermentation, increased expression of proglucagon (gene for GLP-1) and peptide YY (PYY) genes in the large intestine, and improved health. To determine what other genes are up- or downregulated with feeding of HAM-RS2, a microarray was performed. Methods: Adult, male Sprague Dawley rats were fed one of the following three diets for a 4-week study period: cornstarch control (CC, 3.74 kcal/g), dietary energy density control (EC, 3.27 kcal/g), and 30% HAM-RS2 (RS, 3.27 kcal/g). Rat microarray with ∼27,000 genes and validation of 94 representative genes with multiple qPCR were used to determine gene expression in total RNA extracts of cecal cells from rats. The RS versus EC comparison tested effects of fermentation as energy density of the diet was controlled. Results: For the RS versus EC comparison, 86% of the genes were validated from the microarray and the expression indicates promotion of cell growth, proliferation, differentiation, and apoptosis. Gut hormones GLP-1 and PYY were increased. Conclusions: Gene expression results predict improved structure and function of the GI tract. Production of gut hormones may promote healthy functions beyond the GI tract.

Effects of Modification of Encapsulant Materials on the Susceptibility of Fish Oil Microcapsules to Lipolysis

The aim of the study was to assess the effects of modification of encapsulant materials before emulsion formation on the viscosity and interfacial properties of the emulsions and their influence on the susceptibility of emulsions to in vitro lipolysis. Emulsions (oil/protein ratio 2:1) were prepared by homogenizing mixtures containing fish oil and non-heated or heated (100 °C/120 min) dispersions comprising (a) sodium caseinate (NaCas), (b) mixtures of NaCas and a high amylose-resistant starch (Hylon VII; 1:1 mass ratio), and (c) mixtures of NaCas and previously modified resistant starch (heat/microfluidized [MF] Hylon VII; 1:1 mass ratio), followed by freeze drying. Reconstituted emulsion containing heated mixture of NaCas and heat/MF Hylon VII was the most viscous. The extent of lipolysis was the same in all emulsions stabilized by non-heated NaCas or non-heated mixtures of NaCas with resistant starch. Heat treatment of NaCas increased lipolysis of emulsions stabilized with protein alone, but heating NaCas with Hylon VII or heat/MF Hylon VII before emulsion formation reduced lipolysis. The emulsion stabilized with the heated NaCas–heat/MF Hylon VII mixture was the most resistant to lipolysis. Overall, the resistance to lipolysis was considered to be primarily dependent on the interfacial properties of the microcapsules. These findings of in vitro lipolysis of NaCas-resistant starch formulated oil powders may be relevant to an understanding of in vivo digestibility of the oil powders. The insights may be used as a guide to formulate oil systems for altering the susceptibility to lipolysis of ingested oil emulsions.